slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 13,981-14,010
Pages 1,437
Rows per page 30
Arc
13,981-14,010 of 43,093
23
The slide highlights that classified loans represent 1.1% of the total loan portfolio.Central Pacific Financial | Results Presentation Deck | 26 slides · Central Pacific Financial Corp
Conference presentation Investor relations Beat · Solution1 hit
24
Central Pacific Financial | Results Presentation Deck | 26 slidesCentral Pacific Financial | Results Presentation Deck | 26 slides · Central Pacific Financial Corp
Conference presentation Investor relations Beat · Team1 hit
25
Slide 25 of a presentation deck.Central Pacific Financial | Results Presentation Deck | 26 slides · Central Pacific Financial Corp
Conference presentation Investor relations Beat · Team1 hit
26
The table provides adjusted financial figures by removing PPP-related balances and income.Central Pacific Financial | Results Presentation Deck | 26 slides · Central Pacific Financial Corp
Conference presentation Investor relations Beat · The Ask1 hit
04
The slide uses a causal flow from top-level systemic problems to downstream symptoms, followed by a solution-oriented callout box.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a bubble chart to show market growth and a list to show drivers.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a combination of big numbers, a bar chart for revenue, and a line chart for market share to demonstrate rapid growth.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
12
The table compares copays, deductibles, and annual/lifetime costs across four categories.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · TractionLoop · Why Now1 hit
13
The slide uses a highlight color for Clover to differentiate it from competitors.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · TractionLoop · Why Now1 hit
30
Includes run-rate projection for 1H20 revenue and specific MCR metrics for 2020 periods.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
31
The chart shows a negative Year 1 contribution followed by positive contributions in years 2-6.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
32
Clover Health | SPAC Presentation Deck | 46 slidesClover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
33
The chart shows a downward trend in MCR from 89.2% in FY2019 to 82.0% in Q1 2020, with a projected future improvement.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
34
Includes detailed footnotes explaining MCR and Adjusted EBITDA definitions.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
35
The slide uses three bar charts to illustrate revenue growth, medical care ratio trends, and the path to positive EBITDA margin.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
36
Includes historical data (A) and estimates (E). Contains footnotes regarding non-GAAP measures.Clover Health | SPAC Presentation Deck | 46 slides · Clover Health
Pitch deck Investment bank Beat · Financials1 hit
08
Codiak | IPO Presentation Deck | 36 slidesCodiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a process flow diagram to show how PTGFRN/BASP-1 fusion proteins are used to anchor specific targets to the exosome membrane.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a process flow diagram to demonstrate the versatility of the exosome loading technology.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses a combination of bar charts, line charts, and fluorescence microscopy images to validate the platform's targeting capabilities.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
The slide uses a combination of anatomical diagrams, PET/CT imaging, and histological staining to prove the platform's versatility.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
Uses a causal chain/process flow to define the therapeutic index and the factors that expand it.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide highlights the core value proposition of the company's proprietary platform.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The slide uses a Gantt-style visualization to show the development status of various drug candidates.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
17
Codiak | IPO Presentation Deck | 36 slidesCodiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
18
Includes a diagram of the exosome structure with IL-12 displayed on the surface.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
19
Includes three distinct charts: MC38 tumor growth over time, MC38 re-challenge tumor volume, and antigen-specific CD8+ T cell levels.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
20
Includes a table of indications and incidence rates for expansion, and specific trial design details for Part A and Part B.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
21
Includes a diagram of the engineered exosome and a summary of clinical trial status.Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit
22
The slide uses a 2x2 matrix layout to compare two treatments (FSA vs exoSTING) across two time points (4h vs 24h).Codiak | IPO Presentation Deck | 36 slides · Codiak
Pitch deck Investment bank Beat · Roadmap1 hit